View Older Stories

Feb 23, 2026 05:19AM Vanda Pharmaceuticals (VNDA) call put ratio 4.2 calls to 1 put into announces FDA approval of Bysanti tablets

Feb 20, 2026 04:22PM Vanda Pharmaceuticals (VNDA) halted, news pending

Feb 12, 2026 07:21AM Vanda Pharmaceuticals (VNDA) files $200M mixed shelf

Feb 11, 2026 04:03PM Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 83c, provides guidance

Jan 8, 2026 07:01AM FDA rejects Vanda's HETLIOZ application for jet lag disorder

Jan 5, 2026 06:41AM Vanda Pharmaceuticals (VNDA) PT Raised to $22 at H.C. Wainwright

Dec 31, 2025 03:12PM Vanda Pharmaceuticals (VNDA) call put ratio 9.7 calls to 1 puts with a focus on January 8 and 9 calls

Dec 31, 2025 10:13AM Increasing unusual option volume: EWC VNDA TKO XERS CORT ZSL BXSL OTLK PSQ CDZI

Dec 31, 2025 04:25AM Vanda Pharmaceuticals (VNDA) PT Raised to $7.50 at Jefferies

Dec 17, 2025 07:30AM Vanda Pharmaceuticals (VNDA) Reiterated at Outperform by Cantor Fitzgerald

Dec 15, 2025 07:01AM Vanda submits FDA application for rare skin disorder drug

Dec 4, 2025 04:22PM FDA lifts clinical hold on Vanda's motion sickness drug tradipitant

Dec 1, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Nov 28, 2025 07:00AM Vanda gets FDA extension for tradipitant motion sickness drug review

Nov 5, 2025 02:42AM B.Riley Starts Vanda Pharmaceuticals (VNDA) at Buy

Oct 29, 2025 04:05PM Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 5c ; Offers Guidance

Oct 28, 2025 03:07PM Vanda Pharmaceuticals (VNDA) 2300 contracts of January 6 calls trade

Oct 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Oct 1, 2025 05:03PM Vanda Pharmaceuticals reaches dispute resolution framework with FDA

Sep 25, 2025 08:03AM Vanda publishes study showing HETLIOZ improved sleep in insomnia patients

Aug 28, 2025 07:00AM Vanda Pharmaceuticals receives FDA orphan drug status for polycythemia vera drug

Aug 21, 2025 04:40PM Vanda requests FDA commissioner review of generic Hetlioz approvals

Aug 21, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Aug 18, 2025 07:01AM Federal appeals court overturns FDA denial of Vanda's jet lag drug

Jul 31, 2025 07:46AM Vanda Pharmaceuticals (VNDA) Misses Q2 EPS by 17c ; Offers Guidance

May 14, 2025 09:03AM Cantor Fitzgerald Reiterates Overweight Rating on Vanda Pharmaceuticals (VNDA)

May 7, 2025 04:12PM Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 2c, provides guidance

May 5, 2025 08:00AM Vanda Pharmaceuticals (VNDA) Announces Bysanti NDA Filing; FDA Decision Expected in Early 2026

Apr 23, 2025 03:57PM Vanda Pharmaceuticals (VNDA): FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

Mar 31, 2025 08:00AM Vanda Pharmaceuticals (VNDA) Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

Mar 19, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Mar 13, 2025 06:58AM Cantor Biotech industry report, buying value in RevGens

Feb 24, 2025 07:06AM Vanda Pharmaceuticals (VNDA) announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

Feb 18, 2025 06:44AM Vanda Pharmaceuticals (VNDA) PT Raised to $20 at H.C. Wainwright

Feb 14, 2025 07:06AM Cantor Fitzgerald Reiterates Overweight Rating on Vanda Pharmaceuticals (VNDA)

Feb 13, 2025 04:03PM Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 9c ; Offers Guidance

Feb 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Feb 3, 2025 07:30AM Vanda Pharmaceuticals (VNDA) and Anaptys (ANAB) Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab

Jan 28, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)

Jan 27, 2025 07:18AM Vanda Pharmaceuticals (VNDA) Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis

Jan 8, 2025 04:18PM Vanda Pharmaceuticals' (VNDA) Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Dec 20, 2024 09:14AM Vanda Pharmaceuticals (VNDA) Granted FDA Orphan Drug Designation for VGT-1849A

Nov 6, 2024 04:06PM Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 7c, updates guidance

Oct 14, 2024 10:57AM Vanda Pharmaceuticals (VNDA) Confirms Receipt of $8/sh Non-Binding Proposal from Cycle Group Holdings

Oct 14, 2024 08:19AM Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals (VNDA) for $8/sh

Sep 19, 2024 08:10AM Vanda Pharmaceuticals (VNDA) Falls 13% After FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Sep 19, 2024 08:09AM Vanda Pharmaceuticals (VNDA): FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Aug 1, 2024 06:35AM Vanda Pharmaceuticals (VNDA) PT Raised to $13 at Cantor Fitzgerald

Jul 31, 2024 04:04PM Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 5c, provides guidance

Jul 11, 2024 06:36AM Cantor Fitzgerald Starts Vanda Pharmaceuticals (VNDA) at Overweight

View Older Stories